期刊文献+

大肠癌中WIF-1和Wnt2b的表达及其临床意义 被引量:6

Expression and clinical significance of WIF-1 and Wnt2b in colorectal carcinoma
暂未订购
导出
摘要 目的通过检测WIF-1与Wnt2b在正常大肠黏膜、大肠腺瘤、大肠癌中的表达及其与大肠癌生成、侵袭转移之间的关系,探讨WIF-1与Wnt2b之间的关系。方法应用免疫组化SP法检测WIF-1和Wnt2b蛋白在15例癌旁正常组织、18例大肠腺瘤和103例大肠癌组织中的表达。结果 (1)WIF-1蛋白在大肠癌中的阳性率明显低于癌旁正常组织和腺瘤;Wnt2b蛋白在大肠癌中的阳性率高于癌旁正常组织和腺瘤。(2)WIF-1在大肠癌中的表达与患者的年龄、性别、分化程度、浸润程度、淋巴转移和远处转移均无关系(P>0.05);Wnt2b在大肠癌中的表达与大肠癌的分化程度、Dukes分期、淋巴结转移和远处器官转移相关(P<0.05),而与患者的年龄、性别均无关(P>0.05)。(3)大肠癌中WIF-1与Wnt2b的表达呈负相关(r=-0.199,P<0.05)。结论 WIF-1在正常大肠组织中呈阳性表达,在大肠癌的发病机制中可能发挥一定作用;Wnt2b的表达与大肠癌的发生、侵袭转移有关,联合检测WIF-1和Wnt2b有助于大肠癌的诊断、预防和治疗。 Purpose To study the expression of wnt inhibitor factor-1 ( WIF-1 ) and Wnt2b in human adjacent normal colorectal muco- sa, adenomas and eoloreetal carcinoma with invasion and metastasis, and to explore the correlation between WIF-1 and Wnt2b. Meth- ods The expression of WIF-1 and Wnt2b was detected by immunhistochemical staining ( streptavidine-peroxidase method) in adjacent normal coloreetal mucosa, adenomas and eoloreetal carcinoma. Results ( 1 ) The expression rate of WIF-1 in eolorectal carcinoma was significantly lower than that in adjacent normal coloreetal mucosa and adenomas, and that of Wnt2b in eolorectal carcinoma was significantly higher than that in adjacent normal colorectal mucosa and adenomas. (2) The expression of WIF-1 in colorectal carcinoma did not correlate with the patients, age, gender, tumor size, Dukes stages, lymph node status and metastasis (P 〉 0. 05). The expres- sion of Wnt2b in eoloreetal carcinoma did not correlate with the patients' age, gender ( P 〉 0. 05 ) , but correlated with tumor size, Dukes stages, lymph node status and metastasis (P 〈 0. 05 ). ( 3 ) The expression of WIF-1 and Wnt2b was negatively related in the colorectal carcinoma ( r = - 0. 199, P 〈 0. 05 ). Conclusion WIF-1 express periodically in normal colorectal, and may play a role in the pathogenesis of colorectal cancer, and the expression of Wnt2b is correlated with tumorigenesis and invasion and metastasis. Com- bined detection of WIF-1 and Wnt2b can serve as a parametar for diagnosis of colorectal carcinoma and help for its prevention and treat- ment.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第6期613-615,619,共4页 Chinese Journal of Clinical and Experimental Pathology
关键词 大肠肿瘤 WIF-1 Wnt2b 免疫组织化学 colorectal neoplasms WIF-1 Wnt2b immunhistochemistry
  • 相关文献

参考文献3

二级参考文献22

  • 1肖秀英,孙孟红.Wnt信号转导通路与肿瘤的研究进展[J].临床与实验病理学杂志,2005,21(3):351-354. 被引量:7
  • 2赵彤,朱梅刚,黄宗义,张亚历,张素娟,李梅芳.肺癌癌基因蛋白产物同步检测的对比分析[J].癌症,1995,14(1):13-15. 被引量:54
  • 3谷化平,冯和平,徐志勇,苏红.免疫组化在恶性黑色素瘤诊断中的作用[J].中国肿瘤临床,1996,23(8):599-600. 被引量:4
  • 4HSIEH J C,KODJABACHIAN L,REBBERT M L,et al.A new secreted protein that binds to Wnt proteins and inhibits their activities[J].Nature,1999,398(6726):431-436.
  • 5HUNTER DD,ZHANG M.The extracellular matrix component WI-F-1 is expressed during,and can modulate,retinal development[J].Mol Cell Neurosci,2004,27(4):477-488.
  • 6WISSMANN C,JOHANNES P.WIF1,a component of the Wnt pa-thway,is down-regulated in prostate,breast,lung,and bladder cancer[J].Pathology,2003,201(2):204-212.
  • 7CEBRAT M,STRZADALA L,KISIELOW P.Wnt inhibitory factor-1:a candidate for a new player in tumorigenesis of intestinal epithelial cells[J].Cancer Lett,2004,206(1):107-113.
  • 8MAZIERES J,HE B.Wnt Inhibitory factor-1 is silenced by promoter hypermethylation in human lung Cancer[J].Cancer Res,2004,64(14):4717-4720.
  • 9LIN Y C,YOU L,XU Z,et al.Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines[J].Biochem Biophys Res Commun,2006,341(2):635-640.
  • 10CHAN S L,CUI Y,HASSELT A V,et al.The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas[J].Lab Invest,2007:1-7.

共引文献1379

同被引文献79

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1379
  • 2马骏,王国骅,蔡定芳,范越,顾喜喜.健脾消瘤方预防大肠癌术后转移复发的临床观察[J].上海中医药杂志,2005,39(1):24-25. 被引量:29
  • 3Jemal A, Bray F, Center M M, et al. Global cancer statistics[ J]. CA Cancer J Clin, 201 i ,61 (2) :69 - 90.
  • 4Xie B, Chen J, Liu B, Zhan J. Klotho acts as a tumor suppressor in cancers[J]. PatholOncolRes, 2013,19(4):611-7.
  • 5Lee J, Jeong D J, Kim J, et al. The anti-aging gene KLOTHO is a novel target for epigenetic silencing in human cervical carcinoma [ J ]. Mol Cancer, 2010,9 : 109.
  • 6Yoshikawa H, Matsubara K, Zhou X, et al. WNT10B functional dualism: 13-catenin/Tcf-dependent growth promotion or independ- ent suppression with deregulated expression in cancer[ J]. Mol Biol Cell, 2007,18( 11 ) :4292 -303.
  • 7Cruciat C M, Niehrs C. Secreted and transmembrane Wnt inhibi- tors and activators[ J]. Cold Spring Harb Perspect Biol, 2013,5 (3) :a015081.
  • 8Bui T D, Rankin j, Smith K, et al. A novel human Wnt gene, WNTIOB, maps to 12q13 and is expressed in human breast carci- nomas[ J ]. Oncogene, 1997,14 (10) : 1249 - 53.
  • 9Fernandez-Cobo M, Zammarchi F, Mandeli J, et al. Expression ofWntSA and Wntl0B in non-immortalized breast cancer cells [ J ]. Oncol Rep, 2007,17 (4) :903 - 7.
  • 10Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing [ J ]. Nature, 1997,390(6655) :45 -51.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部